229. 肺胞蛋白症（自己免疫性又は先天性） Autoimmune pulmonary alveolar proteinosis Clinical trials / Disease details

臨床試験数 : 43 / 薬物数 : 34 - (DrugBank : 8) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 14

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03231033 (ClinicalTrials.gov)	August 17, 2017	19/6/2017	PioglitazoneTherapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Prote ...	First in Human Study of Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis	Autoimmune Pulmonary Alveolar Proteinosis	Drug: Pioglitazone	Children's Hospital Medical Center, Cincinnati	NULL	Completed	18 Years	80 Years	All	3	Phase 1	United States

First Previous1Next Last